Synthesis and Structure-Activity Relationship of C-Phenyl D-Glucitol (TP0454614) Derivatives as Selective Sodium-Dependent Glucose Cotransporter 1 (SGLT1) Inhibitors.

C-phenyl D-glucitol derivative heart failure selective sodium-dependent glucose cotransporter 1 inhibitor sodium-dependent glucose cotransporter 1 sodium-dependent glucose cotransporter 2 type 2 diabetes

Journal

Chemical & pharmaceutical bulletin
ISSN: 1347-5223
Titre abrégé: Chem Pharm Bull (Tokyo)
Pays: Japan
ID NLM: 0377775

Informations de publication

Date de publication:
2020
Historique:
entrez: 3 7 2020
pubmed: 3 7 2020
medline: 2 2 2021
Statut: ppublish

Résumé

Sodium-glucose cotransporter 1 (SGLT1) is the primary transporter for glucose absorption from the gastrointestinal tract. While C-phenyl D-glucitol derivative SGL5213 has been reported to be a potent intestinal SGLT1 inhibitor for use in the treatment of type 2 diabetes, no SGLT1 selectivity was found in vitro (IC

Identifiants

pubmed: 32611999
doi: 10.1248/cpb.c20-00089
doi:

Substances chimiques

SLC5A1 protein, human 0
Sodium-Glucose Transporter 1 0
Sorbitol 506T60A25R

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

635-652

Auteurs

Shoichi Kuroda (S)

Chemistry Laboratories, Taisho Pharmaceutical Co., Ltd.

Yohei Kobashi (Y)

Chemistry Laboratories, Taisho Pharmaceutical Co., Ltd.

Madoka Kawamura (M)

Chemistry Laboratories, Taisho Pharmaceutical Co., Ltd.

Kenichi Kawabe (K)

Chemistry Laboratories, Taisho Pharmaceutical Co., Ltd.

Fumiyasu Shiozawa (F)

Pharmaceutical Science Laboratories, Taisho Pharmaceutical Co., Ltd.

Makoto Hamada (M)

Pharmaceutical Science Laboratories, Taisho Pharmaceutical Co., Ltd.

Yuki Shimizu (Y)

Pharmaceutical Science Laboratories, Taisho Pharmaceutical Co., Ltd.

Lisa Okumura-Kitajima (L)

Pharmacology Laboratories, Taisho Pharmaceutical Co., Ltd.

Hiroko Koretsune (H)

Pharmacology Laboratories, Taisho Pharmaceutical Co., Ltd.

Kayo Kimura (K)

Pharmacology Laboratories, Taisho Pharmaceutical Co., Ltd.

Koji Yamamoto (K)

Pharmacology Laboratories, Taisho Pharmaceutical Co., Ltd.

Hiroyuki Kakinuma (H)

Chemistry Laboratories, Taisho Pharmaceutical Co., Ltd.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH